Abilify (a-BILA-fi), a new atypical antipsychotic for schizophrenia and bipolar disorder
October 2009
You'll hear about Abilify (a-BILA-fi), a new atypical antipsychotic for schizophrenia and bipolar disorder.
Abilify (aripiprazole) will be promoted as a "dopamine system stabilizer." That's because it's a partial agonist at dopamine receptors instead of an antagonist like other antipsychotics.
A partial agonist can reduce dopamine activity when it's too high and increase it when it's too low.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive